Marc Dufour

429 total citations
10 papers, 375 citations indexed

About

Marc Dufour is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Marc Dufour has authored 10 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Genetics and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Marc Dufour's work include PI3K/AKT/mTOR signaling in cancer (6 papers), Estrogen and related hormone effects (3 papers) and Cancer Mechanisms and Therapy (2 papers). Marc Dufour is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (6 papers), Estrogen and related hormone effects (3 papers) and Cancer Mechanisms and Therapy (2 papers). Marc Dufour collaborates with scholars based in Switzerland, Canada and United States. Marc Dufour's co-authors include Olivier Dormond, Nicolas Demartines, Yvan de Launoit, Jacques Simard, Didier Roulin, Raymonde Veilleux, Fernand Labrie, Laurent Waselle, Sophie Dauvois and Fernand Labrie and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Molecular Cancer and BMC Cancer.

In The Last Decade

Marc Dufour

10 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marc Dufour Switzerland	9	235	91	84	66	57	10	375
Isabel Conde Spain	13	149 0.6×	72 0.8×	114 1.4×	105 1.6×	85 1.5×	17	408
Mark S. Chapman United States	8	255 1.1×	111 1.2×	141 1.7×	79 1.2×	47 0.8×	10	466
Marinela Méndez‐Pertuz Spain	9	334 1.4×	40 0.4×	87 1.0×	96 1.5×	95 1.7×	11	513
Diane Krill United States	9	214 0.9×	114 1.3×	58 0.7×	42 0.6×	47 0.8×	15	350
Akira Junicho Japan	9	208 0.9×	86 0.9×	76 0.9×	158 2.4×	60 1.1×	14	407
Emi Arimoto‐Ishida Japan	8	303 1.3×	26 0.3×	113 1.3×	92 1.4×	55 1.0×	8	514
Prasenjit Dey United States	7	177 0.8×	103 1.1×	183 2.2×	106 1.6×	79 1.4×	10	357
Anne Myrthue United States	9	153 0.7×	133 1.5×	94 1.1×	132 2.0×	83 1.5×	9	433
Alessandra de Cupis Italy	10	201 0.9×	73 0.8×	84 1.0×	133 2.0×	60 1.1×	15	363
Sonal J. Desai United States	8	186 0.8×	210 2.3×	69 0.8×	155 2.3×	95 1.7×	10	424

Countries citing papers authored by Marc Dufour

Since Specialization

Citations

This map shows the geographic impact of Marc Dufour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Dufour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Dufour more than expected).

Fields of papers citing papers by Marc Dufour

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Dufour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Dufour. The network helps show where Marc Dufour may publish in the future.

Co-authorship network of co-authors of Marc Dufour

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Dufour. A scholar is included among the top collaborators of Marc Dufour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Dufour. Marc Dufour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Dufour, Marc, et al.. (2014). PGE2-induced colon cancer growth is mediated by mTORC1. Biochemical and Biophysical Research Communications. 451(4). 587–591. 37 indexed citations

Dufour, Marc, et al.. (2013). Reactivation of AKT signaling following treatment of cancer cells with PI3K inhibitors attenuates their antitumor effects. Biochemical and Biophysical Research Communications. 438(1). 32–37. 21 indexed citations

Dormond, Olivier, Marc Dufour, Tatsuichiro Seto, Sarah Bruneau, & David M. Briscoe. (2012). Targeting the intragraft microenvironment and the development of chronic allograft rejection. Human Immunology. 73(12). 1261–1268. 16 indexed citations

Dufour, Marc, et al.. (2012). mTOR Inhibition and the Tumor Vasculature. IRIS. 1(1). 11–19. 4 indexed citations

Waselle, Laurent, et al.. (2012). Antitumor activities of ATP-competitive inhibitors of mTOR in colon cancer cells. BMC Cancer. 12(1). 86–86. 39 indexed citations

Roulin, Didier, et al.. (2011). The inhibition of MAPK potentiates the anti-angiogenic efficacy of mTOR inhibitors. Biochemical and Biophysical Research Communications. 407(4). 714–719. 23 indexed citations

Roulin, Didier, et al.. (2011). Targeting renal cell carcinoma with NVP-BEZ235, a dual PI3K/mTOR inhibitor, in combination with sorafenib. Molecular Cancer. 10(1). 90–90. 57 indexed citations

Dufour, Marc, et al.. (2011). Targeting the Mammalian Target of Rapamycin (mTOR) in Cancer Therapy: Lessons from Past and Future Perspectives. Cancers. 3(2). 2478–2500. 47 indexed citations

Launoit, Yvan de, Sophie Dauvois, Marc Dufour, Jacques Simard, & Fernand Labrie. (1991). Inhibition of cell cycle kinetics and proliferation by the androgen 5 alpha-dihydrotestosterone and antiestrogen N,n-butyl-N-methyl-11-[16' alpha-chloro-3',17 beta-dihydroxy-estra-1',3',5'-(10')triene-7' alpha-yl] undecanamide in human breast cancer ZR-75-1 cells.. PubMed. 51(11). 2797–802. 51 indexed citations

10.

Launoit, Yvan de, Raymonde Veilleux, Marc Dufour, Jacques Simard, & Fernand Labrie. (1991). Characteristics of the biphasic action of androgens and of the potent antiproliferative effects of the new pure antiestrogen EM-139 on cell cycle kinetic parameters in LNCaP human prostatic cancer cells.. PubMed. 51(19). 5165–70. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact